Code | 1649C | ||||||||||
MA number | 41/0483/16-S | ||||||||||
Product Form: | tbl flm 100x5 mg (blis.OPA/Al/PVC/Al-kalendár.bal.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 41 - CARDIACA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 15.11.2016 |
SPC: | SPC_Ivabradín Sandoz 5 mg_tbl flm_07_2020.doc |
PIL: | PIL_Ivabradín Sandoz_tbl flm_02_2022.pdf |
Safety feature | Yes |
Data update: | 30.08.2021 |